In the BioHarmony Drug Report Database

"Preview" Icon

Mifepristone

Korlym, Mifeprex (mifepristone) is a small molecule pharmaceutical. Mifepristone was first approved as Korlym on 2000-09-28. It is used to treat brain neoplasms, ectopic pregnancy, hyperglycemia, and meningeal neoplasms in the USA. The pharmaceutical is active against progesterone receptor and glucocorticoid receptor. In addition, it is known to target androgen receptor and nuclear receptor subfamily 1 group I member 2. Korlym’s patent is valid until 2038-08-22 (FDA).

 

Trade Name

 

Korlym, Mifeprex
 

Common Name

 

mifepristone
 

ChEMBL ID

 

CHEMBL1276308
 

Indication

 

brain neoplasms, ectopic pregnancy, hyperglycemia, meningeal neoplasms
 

Drug Class

 

Progesterone receptor antagonists

Image (chem structure or protein)

Mifepristone structure rendering